Literature DB >> 20478358

Accumulation of oxidative DNA damage in brain mitochondria in mouse model of hereditary ferritinopathy.

Xiaoling Deng1, Ruben Vidal, Ella W Englander.   

Abstract

Tissue iron content is strictly regulated to concomitantly satisfy specialized metabolic requirements and avoid toxicity. Ferritin, a multi-subunit iron storage protein, is central to maintenance of iron homeostasis in the brain. Mutations in the ferritin light chain (FTL)-encoding gene underlie the autosomal dominant, neurodegenerative disease, neuroferritinopathy/hereditary ferritinopathy (HF). HF is characterized by progressive accumulation of ferritin and iron. To gain insight into mechanisms by which FTL mutations promote neurodegeneration, a transgenic mouse, expressing human mutant form of FTL, was recently generated. The FTL mouse exhibits buildup of iron in the brain and presents manifestations of oxidative stress reminiscent of the human disease. Here, we asked whether oxidative DNA damage accumulates in the FTL mouse brain. Long-range PCR (L-PCR) amplification-mediated DNA damage detection assays revealed that the integrity of mitochondrial DNA (mtDNA) in the brain was significantly compromised in the 12- but not 6-month-old FTL mice. Furthermore, L-PCR employed in conjunction with DNA modifying enzymes, which target specific DNA adducts, revealed the types of oxidative adducts accumulating in mtDNA in the FTL brain. Consistently with DNA damage predicted to form under conditions of excessive oxidative stress, detected adducts include, oxidized guanines, abasic sites and strand breaks. Elevated mtDNA damage may impair mitochondrial function and brain energetics and in the long term contribute to neuronal loss and exacerbate neurodegeneration in HF. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20478358      PMCID: PMC2914088          DOI: 10.1016/j.neulet.2010.05.025

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  32 in total

Review 1.  A brief history of brain iron research.

Authors:  Arnulf H Koeppen
Journal:  J Neurol Sci       Date:  2003-03-15       Impact factor: 3.181

Review 2.  Adventiously-bound redox active iron and copper are at the center of oxidative damage in Alzheimer disease.

Authors:  George Perry; Marta A Taddeo; Robert B Petersen; Rudy J Castellani; Peggy L R Harris; Sandra L Siedlak; Adam D Cash; Quan Liu; Akohiko Nunomura; Craig S Atwood; Mark A Smith
Journal:  Biometals       Date:  2003-03       Impact factor: 2.949

3.  Accumulation of oxidatively generated DNA damage in the brain: a mechanism of neurotoxicity.

Authors:  Liuji Chen; Heung M Lee; George H Greeley; Ella W Englander
Journal:  Free Radic Biol Med       Date:  2006-11-10       Impact factor: 7.376

Review 4.  Role of iron in neurodegenerative disorders.

Authors:  Daniela Berg; Moussa B H Youdim
Journal:  Top Magn Reson Imaging       Date:  2006-02

5.  Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation.

Authors:  Patrick F Chinnery; Douglas E Crompton; Daniel Birchall; Margaret J Jackson; Alan Coulthard; Anne Lombès; Niall Quinn; Adrian Wills; Nicholas Fletcher; John P Mottershead; Paul Cooper; Mark Kellett; David Bates; John Burn
Journal:  Brain       Date:  2006-12-02       Impact factor: 13.501

6.  Clinical phenotype and neuroimaging findings in a French family with hereditary ferritinopathy (FTL498-499InsTC).

Authors:  Fabienne Ory-Magne; Christine Brefel-Courbon; Pierre Payoux; Sabrina Debruxelles; Igor Sibon; Cyril Goizet; Pierre Labauge; Patrice Menegon; Emmanuelle Uro-Coste; Bernardino Ghetti; Marie Bernadetle Delisle; Ruben Vidal; Olivier Rascol
Journal:  Mov Disord       Date:  2009-08-15       Impact factor: 10.338

7.  Oxidative stress and cell death in cells expressing L-ferritin variants causing neuroferritinopathy.

Authors:  Anna Cozzi; Elisabetta Rovelli; Grazia Frizzale; Alessandro Campanella; Mario Amendola; Paolo Arosio; Sonia Levi
Journal:  Neurobiol Dis       Date:  2009-09-23       Impact factor: 5.996

Review 8.  Mitochondrial DNA, base excision repair and neurodegeneration.

Authors:  Nadja C de Souza-Pinto; David M Wilson; Tinna V Stevnsner; Vilhelm A Bohr
Journal:  DNA Repair (Amst)       Date:  2008-05-16

9.  Removal of oxidative DNA damage via FEN1-dependent long-patch base excision repair in human cell mitochondria.

Authors:  Pingfang Liu; Limin Qian; Jung-Suk Sung; Nadja C de Souza-Pinto; Li Zheng; Daniel F Bogenhagen; Vilhelm A Bohr; David M Wilson; Binghui Shen; Bruce Demple
Journal:  Mol Cell Biol       Date:  2008-06-09       Impact factor: 4.272

10.  Oxidative stress induces degradation of mitochondrial DNA.

Authors:  Inna Shokolenko; Natalia Venediktova; Alexandra Bochkareva; Glenn L Wilson; Mikhail F Alexeyev
Journal:  Nucleic Acids Res       Date:  2009-03-05       Impact factor: 16.971

View more
  23 in total

Review 1.  Pathogenic implications of iron accumulation in multiple sclerosis.

Authors:  Rachel Williams; Cassandra L Buchheit; Nancy E J Berman; Steven M LeVine
Journal:  J Neurochem       Date:  2011-11-11       Impact factor: 5.372

2.  Differential effect of nimodipine in attenuating iron-induced toxicity in brain- and blood-brain barrier-associated cell types.

Authors:  J A Lockman; W J Geldenhuys; K A Bohn; S F Desilva; D D Allen; C J Van der Schyf
Journal:  Neurochem Res       Date:  2011-09-21       Impact factor: 3.996

Review 3.  The role of iron in brain ageing and neurodegenerative disorders.

Authors:  Roberta J Ward; Fabio A Zucca; Jeff H Duyn; Robert R Crichton; Luigi Zecca
Journal:  Lancet Neurol       Date:  2014-10       Impact factor: 44.182

Review 4.  Oxidative genome damage and its repair in neurodegenerative diseases: function of transition metals as a double-edged sword.

Authors:  Muralidhar L Hegde; Pavana M Hegde; K S Rao; Sankar Mitra
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

Review 5.  Pathogenic mechanism and modeling of neuroferritinopathy.

Authors:  Anna Cozzi; Paolo Santambrogio; Maddalena Ripamonti; Ermanna Rovida; Sonia Levi
Journal:  Cell Mol Life Sci       Date:  2021-01-13       Impact factor: 9.261

6.  Abnormal iron metabolism in fibroblasts from a patient with the neurodegenerative disease hereditary ferritinopathy.

Authors:  Ana G Barbeito; Thierry Levade; Marie B Delisle; Bernardino Ghetti; Ruben Vidal
Journal:  Mol Neurodegener       Date:  2010-11-10       Impact factor: 14.195

7.  Quantitative Susceptibility Mapping of the Thalamus: Relationships with Thalamic Volume, Total Gray Matter Volume, and T2 Lesion Burden.

Authors:  G C Chiang; J Hu; E Morris; Y Wang; S A Gauthier
Journal:  AJNR Am J Neuroradiol       Date:  2018-01-25       Impact factor: 3.825

Review 8.  Excess iron harms the brain: the syndromes of neurodegeneration with brain iron accumulation (NBIA).

Authors:  Susanne A Schneider; Kailash P Bhatia
Journal:  J Neural Transm (Vienna)       Date:  2012-12-02       Impact factor: 3.575

Review 9.  Brain iron homeostasis: from molecular mechanisms to clinical significance and therapeutic opportunities.

Authors:  Neena Singh; Swati Haldar; Ajai K Tripathi; Katharine Horback; Joseph Wong; Deepak Sharma; Amber Beserra; Srinivas Suda; Charumathi Anbalagan; Som Dev; Chinmay K Mukhopadhyay; Ajay Singh
Journal:  Antioxid Redox Signal       Date:  2013-08-15       Impact factor: 8.401

10.  Iron loading-induced aggregation and reduction of iron incorporation in heteropolymeric ferritin containing a mutant light chain that causes neurodegeneration.

Authors:  Barry B Muhoberac; Martin A Baraibar; Ruben Vidal
Journal:  Biochim Biophys Acta       Date:  2010-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.